Interdisciplinary Bio Central
Conference report (Biological frontiers (General Biology))

The 50th Annual Meeting of American Society of Hematology
Jaehyung Cho1,*
1Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical school
*Corresponding author
  Received : March 03, 2009
  Accepted : March 06, 2009
  Published : March 10, 2009
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Main text PDF(274.KB)
(pre-print version)

This year, the American Society of Hematology (ASH) celebrated its 50th anniversary. The goal of ASH is to prevent and cure hematological diseases through the advancement and sponsorship of basic and clinical research. This year's ASH meeting addressed important research topics including hematologic malignancies, bone marrow transplantation, sickle cell diseases, hematopoietic stem cells, thrombosis, hemostasis, and vascular biology. This report will focus on 1) the discovery of novel anti-coagulant agents, 2) the role of cell-surface molecules in vascular diseases such as sickle cell disease and inflammation, 3) the role of endothelial cells, platelets, and leukocytes in cancer, and 4) the platelet signaling pathway regulated by integrins and other cell adhesion molecules. (

Keyword: vascular disease, thrombosis and hemostasis, inflammation, sickle cell disease, cancer
IBC   ISSN : 2005-8543   Contact IBC